OLUKOTUN ADEOYE Y
Insider CIK 1242615 · DDXS Director · TNXP Director · BIOC Director · ARWR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-08-18 | 2026-08-20 | 2,000 | $86.96 | $173.9K | 31,600 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-08-18 | 2026-08-20 | 2,000 | $86.96 | $173.9K | 31,600 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2026-05-12 | 2026-05-14 | 22,700 | — | $0 | 22,700 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 827 | $68.48 | $56.6K | 33,600 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 6,083 | $68.04 | $413.9K | 34,427 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-19 | 2025-12-23 | 3,090 | $66.70 | $206.1K | 40,510 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 43,600 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2025-05-13 | 2025-05-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-01-23 | 2025-01-27 | 959 | $21.00 | $20.1K | 35,781 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2024-12-27 | 2024-12-30 | 2,850 | $20.00 | $57.0K | 36,740 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 39,590 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | J Other | 2024-06-10 | 2025-02-28 | 1 | $1.91 | $2 | 0 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2024-05-23 | 2024-05-24 | 104,621 | — | $0 | 104,621 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 22,854 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2023-05-08 | 2023-05-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2023-03-03 | 2023-03-06 | 11,350 | $32.65 | $370.6K | 7,867 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 19,217 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2022-05-09 | 2022-05-11 | 2,131,500 | — | $0 | 2,131,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 11,350 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-04 | 1,890 | $64.26 | $121.5K | 7,110 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-04 | 244 | $66.25 | $16.2K | 4,950 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-04 | 1,916 | $65.04 | $124.6K | 5,194 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-14 | 2,750 | $63.76 | $175.3K | 9,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-14 | 2,250 | $63.76 | $143.5K | 11,750 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2021-05-10 | 2021-05-12 | 270,882 | — | $0 | 270,882 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2021-01-01 | 2021-01-05 | 9,000 | — | $0 | 14,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2020-08-13 | 2020-08-17 | 5,350 | $0.94 | $5.0K | 5,350 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2020-05-04 | 2020-05-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2019-05-06 | 2019-05-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2018-09-05 | 2018-09-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DDXS diaDexus, Inc. | A Award deriv | 2014-05-29 | 2014-06-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DDXS diaDexus, Inc. | A Award | 2013-08-06 | 2013-08-08 | 5,958 | — | $0 | 5,958 | SEC↗ |
| DDXS diaDexus, Inc. | A Award deriv | 2013-07-31 | 2013-08-02 | 55,000 | — | $0 | 55,000 | SEC↗ |
| BIOC BIOCLINICA INC | U Tender | 2013-03-12 | 2013-03-14 | 52,000 | $7.25 | $377.0K | 0 | SEC↗ |
| BIOC BIOCLINICA INC | A Award deriv | 2012-05-16 | 2012-05-17 | 12,000 | — | $0 | 52,000 | SEC↗ |